ISpecimen Historical Balance Sheet

ISPC Stock

USD 1.03 0.05 4.63%

Trend analysis of iSpecimen balance sheet accounts such as Other Current Liabilities of 2.3 M or Total Current Liabilities of 7.7 M provides information on ISpecimen's total assets, liabilities, and equity, which is the actual value of iSpecimen to its prevalent stockholders. By breaking down trends over time using ISpecimen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining iSpecimen latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether iSpecimen is a good buy for the upcoming year.

ISpecimen Inventory

0.95

Build AI portfolio with ISpecimen Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iSpecimen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade ISpecimen Stock refer to our How to Trade ISpecimen Stock guide.

About ISpecimen Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of iSpecimen at a specified time, usually calculated after every quarter, six months, or one year. ISpecimen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ISpecimen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ISpecimen currently owns. An asset can also be divided into two categories, current and non-current.

ISpecimen Balance Sheet Chart

At present, ISpecimen's Other Current Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 7.7 M, whereas Short and Long Term Debt Total is forecasted to decline to about 296.6 K.

Short Long Term Debt Total Other Current Liab Total Current Liabilities

Total Current Liabilities

Total Current Liabilities is an item on ISpecimen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of iSpecimen are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from ISpecimen's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into iSpecimen current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iSpecimen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade ISpecimen Stock refer to our How to Trade ISpecimen Stock guide.At present, ISpecimen's Other Current Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 7.7 M, whereas Short and Long Term Debt Total is forecasted to decline to about 296.6 K.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	185.8K	196.2K	312.2K	296.6K
Total Assets	24.6M	15.8M	9.4M	15.7M

Short Long Term Debt Total Total Assets

ISpecimen balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.61	-0.68	-0.7	0.95	0.85	0.2	-0.46	-0.96	-0.55	0.35	0.92	0.5	-0.71	-0.69	0.94	0.97	-0.74	0.64	-0.74	-0.5	0.65	0.89	-0.78	0.98	0.5
Short Long Term Debt Total	-0.61		0.93	0.9	-0.82	-0.9	-0.77	0.71	0.7	0.81	-0.69	-0.39	-0.75	0.65	0.67	-0.42	-0.52	0.6	-0.86	0.91	-0.24	-0.29	-0.81	0.95	-0.73	-0.85
Other Current Liab	-0.68	0.93		0.99	-0.87	-0.88	-0.6	0.57	0.81	0.65	-0.51	-0.57	-0.6	0.48	0.5	-0.59	-0.52	0.45	-0.74	0.8	-0.18	-0.16	-0.83	0.96	-0.8	-0.77
Total Current Liabilities	-0.7	0.9	0.99		-0.87	-0.85	-0.52	0.6	0.84	0.55	-0.4	-0.62	-0.49	0.44	0.45	-0.65	-0.53	0.4	-0.67	0.74	-0.15	-0.1	-0.79	0.94	-0.81	-0.67
Total Stockholder Equity	0.95	-0.82	-0.87	-0.87		0.96	0.46	-0.59	-0.96	-0.7	0.54	0.82	0.66	-0.74	-0.74	0.84	0.88	-0.75	0.78	-0.88	-0.26	0.56	0.96	-0.94	0.99	0.71
Net Tangible Assets	0.85	-0.9	-0.88	-0.85	0.96		0.57	-0.61	-0.86	-0.86	0.68	0.64	0.76	-0.81	-0.82	0.67	0.78	-0.8	0.92	-0.96	-0.16	0.58	0.97	-0.96	0.92	0.83
Property Plant And Equipment Net	0.2	-0.77	-0.6	-0.52	0.46	0.57		-0.58	-0.28	-0.73	0.82	-0.03	0.77	-0.5	-0.53	0.0	0.18	-0.48	0.68	-0.73	0.45	0.24	0.51	-0.68	0.35	0.79
Current Deferred Revenue	-0.46	0.71	0.57	0.6	-0.59	-0.61	-0.58		0.55	0.52	-0.55	-0.34	-0.48	0.69	0.68	-0.37	-0.41	0.56	-0.55	0.62	0.06	-0.26	-0.57	0.66	-0.52	-0.57
Net Debt	-0.96	0.7	0.81	0.84	-0.96	-0.86	-0.28	0.55		0.5	-0.31	-0.93	-0.43	0.62	0.6	-0.94	-0.86	0.62	-0.62	0.72	0.34	-0.46	-0.89	0.85	-0.98	-0.51
Retained Earnings	-0.55	0.81	0.65	0.55	-0.7	-0.86	-0.73	0.52	0.5		-0.91	-0.23	-0.9	0.85	0.88	-0.26	-0.56	0.86	-0.97	0.94	0.04	-0.68	-0.81	0.77	-0.63	-0.9
Accounts Payable	0.35	-0.69	-0.51	-0.4	0.54	0.68	0.82	-0.55	-0.31	-0.91		0.04	0.95	-0.79	-0.82	0.1	0.4	-0.79	0.81	-0.83	0.01	0.63	0.69	-0.67	0.46	0.93
Cash	0.92	-0.39	-0.57	-0.62	0.82	0.64	-0.03	-0.34	-0.93	-0.23	0.04		0.17	-0.47	-0.43	1.0	0.85	-0.49	0.36	-0.47	-0.56	0.44	0.73	-0.61	0.88	0.22
Non Current Assets Total	0.5	-0.75	-0.6	-0.49	0.66	0.76	0.77	-0.48	-0.43	-0.9	0.95	0.17		-0.77	-0.81	0.24	0.54	-0.8	0.81	-0.89	0.01	0.65	0.76	-0.75	0.59	0.93
Non Currrent Assets Other	-0.71	0.65	0.48	0.44	-0.74	-0.81	-0.5	0.69	0.62	0.85	-0.79	-0.47	-0.77		1.0	-0.5	-0.77	0.98	-0.84	0.85	0.47	-0.85	-0.82	0.68	-0.72	-0.73
Other Assets	-0.69	0.67	0.5	0.45	-0.74	-0.82	-0.53	0.68	0.6	0.88	-0.82	-0.43	-0.81	1.0		-0.46	-0.75	0.98	-0.85	0.87	0.42	-0.84	-0.83	0.7	-0.71	-0.77
Cash And Short Term Investments	0.94	-0.42	-0.59	-0.65	0.84	0.67	0.0	-0.37	-0.94	-0.26	0.1	1.0	0.24	-0.5	-0.46		0.87	-0.52	0.38	-0.51	-0.56	0.47	0.76	-0.64	0.91	0.28
Net Receivables	0.97	-0.52	-0.52	-0.53	0.88	0.78	0.18	-0.41	-0.86	-0.56	0.4	0.85	0.54	-0.77	-0.75	0.87		-0.81	0.61	-0.73	-0.59	0.79	0.84	-0.67	0.92	0.46
Common Stock Total Equity	-0.74	0.6	0.45	0.4	-0.75	-0.8	-0.48	0.56	0.62	0.86	-0.79	-0.49	-0.8	0.98	0.98	-0.52	-0.81		-0.83	0.86	0.5	-0.93	-0.84	0.66	-0.74	-0.72
Common Stock Shares Outstanding	0.64	-0.86	-0.74	-0.67	0.78	0.92	0.68	-0.55	-0.62	-0.97	0.81	0.36	0.81	-0.84	-0.85	0.38	0.61	-0.83		-0.95	-0.05	0.62	0.86	-0.84	0.71	0.86
Non Current Liabilities Total	-0.74	0.91	0.8	0.74	-0.88	-0.96	-0.73	0.62	0.72	0.94	-0.83	-0.47	-0.89	0.85	0.87	-0.51	-0.73	0.86	-0.95		0.06	-0.66	-0.92	0.92	-0.82	-0.9
Inventory	-0.5	-0.24	-0.18	-0.15	-0.26	-0.16	0.45	0.06	0.34	0.04	0.01	-0.56	0.01	0.47	0.42	-0.56	-0.59	0.5	-0.05	0.06		-0.66	-0.31	-0.03	-0.37	0.08
Other Current Assets	0.65	-0.29	-0.16	-0.1	0.56	0.58	0.24	-0.26	-0.46	-0.68	0.63	0.44	0.65	-0.85	-0.84	0.47	0.79	-0.93	0.62	-0.66	-0.66		0.67	-0.4	0.6	0.49
Other Stockholder Equity	0.89	-0.81	-0.83	-0.79	0.96	0.97	0.51	-0.57	-0.89	-0.81	0.69	0.73	0.76	-0.82	-0.83	0.76	0.84	-0.84	0.86	-0.92	-0.31	0.67		-0.93	0.95	0.82
Total Liab	-0.78	0.95	0.96	0.94	-0.94	-0.96	-0.68	0.66	0.85	0.77	-0.67	-0.61	-0.75	0.68	0.7	-0.64	-0.67	0.66	-0.84	0.92	-0.03	-0.4	-0.93		-0.88	-0.85
Net Invested Capital	0.98	-0.73	-0.8	-0.81	0.99	0.92	0.35	-0.52	-0.98	-0.63	0.46	0.88	0.59	-0.72	-0.71	0.91	0.92	-0.74	0.71	-0.82	-0.37	0.6	0.95	-0.88		0.63
Property Plant And Equipment Gross	0.5	-0.85	-0.77	-0.67	0.71	0.83	0.79	-0.57	-0.51	-0.9	0.93	0.22	0.93	-0.73	-0.77	0.28	0.46	-0.72	0.86	-0.9	0.08	0.49	0.82	-0.85	0.63

Click cells to compare fundamentals

ISpecimen Account Relationship Matchups

ISpecimen balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	6.2M	35.7M	24.6M	15.8M	9.4M	15.7M
Short Long Term Debt Total	12.8M	3.4M	185.8K	196.2K	312.2K	296.6K
Other Current Liab	6.9M	1.0M	1.4M	1.5M	1.2M	2.3M
Total Current Liabilities	22.1M	2.5M	4.3M	6.0M	5.8M	7.7M
Total Stockholder Equity	(27.3M)	29.8M	20.3M	9.7M	3.3M	3.5M
Net Tangible Assets	(25.0M)	(29.9M)	27.1M	15.8M	18.2M	19.1M
Property Plant And Equipment Net	75.6K	32.8K	410.5K	321.6K	421.5K	240.6K
Current Deferred Revenue	873.3K	654.7K	132.3K	415.8K	360.7K	630.7K
Net Debt	12.1M	(24.3M)	(15.1M)	(2.1M)	(1.6M)	(1.6M)
Retained Earnings	(29.1M)	(38.0M)	(48.3M)	(59.4M)	(71.9M)	(68.3M)
Accounts Payable	1.8M	832.7K	2.5M	3.9M	4.2M	2.3M
Cash	695.9K	27.7M	15.3M	2.3M	1.9M	1.8M
Non Current Assets Total	2.7M	2.8M	4.9M	7.6M	5.8M	4.4M
Cash And Short Term Investments	695.9K	27.7M	15.3M	5.0M	1.9M	1.8M
Net Receivables	2.4M	4.9M	3.9M	2.9M	1.4M	2.8M
Common Stock Shares Outstanding	46.8K	408.6K	442.2K	452.1K	710.9K	746.4K
Liabilities And Stockholders Equity	6.2M	35.7M	24.6M	15.8M	9.4M	15.7M
Non Current Liabilities Total	11.4M	3.4M	27.4K	29.1K	268.8K	255.4K
Other Current Assets	417.9K	327.0K	300.4K	292.1K	264.9K	301.0K
Other Stockholder Equity	(9.4M)	103.5M	68.6M	69.1M	75.2M	45.2M
Total Liab	33.5M	5.9M	4.3M	6.1M	6.0M	12.0M
Net Invested Capital	(14.5M)	33.2M	20.3M	9.7M	3.3M	4.5M
Property Plant And Equipment Gross	75.6K	340.1K	410.5K	766.4K	763.6K	412.5K
Total Current Assets	3.5M	32.9M	19.7M	8.2M	3.6M	3.4M
Capital Stock	94.0	873.0	892.0	908.0	170.0	161.5
Net Working Capital	(18.7M)	30.4M	15.4M	2.2M	(2.2M)	(2.1M)
Short Term Debt	10.6M	12.6M	316.9K	167.1K	43.4K	41.2K
Intangible Assets	2.6M	2.7M	4.5M	7.2M	5.3M	4.1M
Common Stock	94.0	873.0	892.0	908.0	170.0	161.5
Property Plant Equipment	119.9K	75.6K	32.8K	410.5K	472.1K	495.7K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GOOG	Alphabet Inc Class C
V	Visa Class A

When determining whether iSpecimen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ISpecimen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ispecimen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ispecimen Stock:

How To Invest In ISpecimen

Details

Is ISpecimen Stock a good investment?

Details

What is ISpecimen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade ISpecimen Stock refer to our How to Trade ISpecimen Stock guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ISpecimen. If investors know ISpecimen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ISpecimen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(11.93)

Revenue Per Share

6.844

Quarterly Revenue Growth

(0.54)

Return On Assets

(0.73)

Return On Equity

(2.65)

The market value of iSpecimen is measured differently than its book value, which is the value of ISpecimen that is recorded on the company's balance sheet. Investors also form their own opinion of ISpecimen's value that differs from its market value or its book value, called intrinsic value, which is ISpecimen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ISpecimen's market value can be influenced by many factors that don't directly affect ISpecimen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ISpecimen's value and its price as these two are different measures arrived at by different means. Investors typically determine if ISpecimen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ISpecimen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

ISpecimen Historical Balance Sheet

ISpecimen Inventory

0.95

About ISpecimen Balance Sheet Analysis

ISpecimen Balance Sheet Chart

Total Current Liabilities

ISpecimen balance sheet Correlations

ISpecimen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ISpecimen balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Other Assets	+ 1.0	Non Currrent Assets Other
Total Current Liabilities	+ 0.99	Other Current Liab
Net Invested Capital	+ 0.99	Total Stockholder Equity
Net Invested Capital	+ 0.98	Total Assets
Common Stock Total Equity	+ 0.98	Non Currrent Assets Other

Net Invested Capital	- 0.98	Net Debt
Common Stock Shares Outstanding	- 0.97	Retained Earnings
Total Liab	- 0.96	Net Tangible Assets
Non Current Liabilities Total	- 0.96	Net Tangible Assets
Net Debt	- 0.96	Total Stockholder Equity
Net Debt	- 0.96	Total Assets